Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report

Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report

IntroductionClozapine and chlorpromazine are widely used for treating schizophrenia. However, irregular medical follow-ups are common in patients with schizophrenia, potentially leading to long-term super-dose medication. Managing such cases poses significant challenges for clinical psychiatrists.Ca...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaobo Xie, Jinzhang Chen, Hongli Song, Zebin Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Psychiatry
Subjects:	clozapine chlorpromazine antipsychotics schizophrenia case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1533350/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
by: Mulualem Kelebie, et al.
Published: (2025-02-01)

Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders
by: Bole Cvetka Bačar, et al.
Published: (2017-03-01)

Disability and quality of life in patients with treatment-resistant schizophrenia on long- term clozapine therapy
by: Dhandapani Nandakumar, et al.
Published: (2023-06-01)

Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
by: Ramandeep Kaur, et al.
Published: (2023-04-01)

Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
by: Letizia Biso, et al.
Published: (2025-01-01)

Prevalence of obsessive-compulsive symptoms in patients with schizophrenia treated with clozapine: a scoping review
by: Evelyn Moreno Tarazona, et al.
Published: (2025-01-01)

Association between treatment resistance and cognitive function in schizophrenia
by: Jiaqian Sun, et al.
Published: (2024-10-01)

Antipsychotic-induced hyperprolactinemia: Toxicologic mechanism and the increased breast cancer risk
by: Steven B. Bird
Published: (2025-06-01)

The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force
by: Hélène Verdoux, et al.
Published: (2025-01-01)

Expression study of Wnt/β-catenin signaling pathway associated lncRNAs in schizophrenia
by: Fatemeh Manafzadeh, et al.
Published: (2025-01-01)

Effect of Atypical Antipsychotic Usage at Therapeutic Doses on Daytime Sleepiness
by: Birol Topcu, et al.
Published: (2023-09-01)

Experience with and attitude toward clozapine use among patients receiving clozapine on long term and their caregivers
by: Sandeep Grover, et al.
Published: (2023-11-01)

Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting
by: Christoph U. Correll, et al.
Published: (2025-01-01)

Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
by: Miquel Bernardo, et al.
Published: (2025-01-01)

Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01)

Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis [version 2; peer review: 1 approved, 2 approved with reservations]
by: Spyridon Siafis, et al.
Published: (2025-01-01)

The Role of Neuroglia in the Development and Progression of Schizophrenia
by: Neha S. Rawani, et al.
Published: (2024-12-01)

The Safety of Ondansetron and Chlorpromazine for Hyperemesis Gravidarum in First Trimester Pregnancy
by: Şafak Özdemirci, et al.
Published: (2014-08-01)

Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children
by: Sophie A. Kitchen, et al.
Published: (2025-02-01)

Schizophrenia and Nicotine - A Bittersweet Psychiatric Story
by: Satrajit Ghosal, et al.
Published: (2025-01-01)

Quality of life in persons with schizophrenia
by: Zack Cernovsky
Published: (2017-03-01)

Relation of Vitamin D levels with positive and negative symptoms of schizophrenia – A hospital based cross-sectional comparative study
by: Soumitra Ghosh, et al.
Published: (2023-09-01)

Dropout rates and reasons for dropout among patients receiving clozapine
by: Sandeep Grover, et al.
Published: (2023-06-01)

The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
by: Indah Kurnia Utami, et al.
Published: (2024-11-01)

Gratitude in the recovery process: perspectives of women and men with schizophrenia
by: Iwona Michalczuk, et al.
Published: (2024-11-01)

Schizophasia and Cognitive Impairment in Schizophrenia: A Literature Review
by: Sylwia Niedźwiadek, et al.
Published: (2024-12-01)

Inductive Reasoning in Patients with Paranoid Type Schizophrenia
by: Mehmet Emrah Karadere, et al.
Published: (2017-08-01)

The Validity and Reliability of the Turkish version of Knowledge About Schizophrenia Questionnaire (KASQ)
by: Sevgi Dicle Gorkem Atalan, et al.
Published: (2018-04-01)

Development and validation of a recurrence risk prediction model for elderly schizophrenia patients
by: Biqi Zu, et al.
Published: (2025-01-01)

Comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia
by: Sanya Sharma, et al.
Published: (2023-10-01)

Gender differences in the influencing factors of violent behavior in patients with schizophrenia
by: Xiaolei Qiu, et al.
Published: (2025-01-01)

Metformin for neurocognitive dysfunction in schizophrenia: a systematic review
by: Zhen-Juan Qin, et al.
Published: (2025-01-01)

Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluation
by: Ali Ahmed Mahmoud Abdelhaleem, et al.
Published: (2015-06-01)

Effects of Pickleball Intervention on the Self-Esteem and Symptoms of Patients with Schizophrenia
by: Tsai-Chieh Chien, et al.
Published: (2025-01-01)

Evaluation of a Deep Learning Model for Automatic Detection of Schizophrenia Using EEG Signals
by: Swetha Padmavathi Polisetty, et al.
Published: (2024-06-01)

The Management of Social Phobia Ýn Residual-Type Schizophrenia with Cognitive Behavioral Therapy
by: Elif Þimþek Kaygusuz, et al.
Published: (2015-04-01)

Resilience and its relationship with disability in persons with bipolar disorder and schizophrenia: A comparative study
by: Arnab Datta, et al.
Published: (2023-03-01)

Ferroptosis as a potential connection between schizophrenia and metabolic dysfunction-associated steatotic liver disease – a narrative review
by: Jakub Rogalski, et al.
Published: (2024-09-01)

Family intervention for expressed emotion in schizophrenia: Indian context
by: Kannappa V. Shetty, et al.
Published: (2023-04-01)

Prevalence, correlates and explanatory models of cognitive deficits in patients with schizophrenia—A cross sectional study
by: Chithra Uppinkudru, et al.
Published: (2023-10-01)